| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT04188405 Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia… |
Trial completed |
| 2026-06-06 | NCT04188405 Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia… |
date change Primary completion moved earlier: 2026-11-30 -> 2026-06-02 |
| 2026-06-06 | NCT04188405 Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia… |
date change Completion moved earlier: 2026-11-30 -> 2026-06-02 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04530565 | Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or… | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Active, Not Recruiting |
| Phase 2 | |||
| NCT01746836 | Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid… | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recruiting |
| NCT07224100 | Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of… | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Recruiting |
| NCT03263572 | Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With… | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recruiting |
| NCT03739814 | Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT04747912 | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With… | Lymphoblastic Leukemia | Recruiting |
| NCT03147612 | Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With… | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Active, Not Recruiting |
| NCT05306301 | Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients | Chemotherapy | Active, Not Recruiting |
| NCT01424982 | Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute… | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06207123 | A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in… | Acute Leukemia | Recruiting |
| NCT03934372 | Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory… | Acute Myeloid Leukemia | Recruiting |